Company intelligence / Profile preview

SAW Instruments

Bonn, Germany

Ownership: Private
Development stage: Other

Overview

SAW Instruments develops and commercializes Surface Acoustic Wave biosensors for real-time, label-free measurement of biomolecular interactions. The technology can measure binding to whole cells, small molecules, and fragment libraries, and is uniquely capable of measuring conformational changes in cells, membranes, and vesicles.

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

ACOBIO K.K. (exclusive distribution agreement for Japan)

Beyond the preview

Go deeper on SAW Instruments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SAW Instruments.

Explore the full profile